National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No. 2) (No. PB 66 of 2011) (Cth)
PB 66 of 2011
National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No 2.)
National Health Act 1953
___________________________________________________________________________
I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 26 August 2011
FELICITY MCNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No.2).
(2)This Instrument may also be cited as PB 66 of 2011.
2 Commencement
This Instrument commences on 1 September 2011.
3 Amendments to PB 115 of 2010
Schedule 1 amends the National Health (Trastuzumab) Special Arrangement 2010 (PB 115 of 2010)
.
Schedule 1 Amendments
Section 4, definition of ‘approved hospital authority’, Subparagraph (a)(ii)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 11, Paragraph (2)(a)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 11, Paragraph (2)(b)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 12, Paragraph (1)(a)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 12, Paragraph (1)(b)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 12, Paragraph (1)(c)
omit (all instances):
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 12, Paragraph (2)(a)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 12, Subsection (3)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
Section 13, Subsection (1)
Omit (all instances):
Medicare Australia CEO
substitute:
Chief Executive Medicare
[10] Section 13, Subsection (2)
Omit (all instances):
Medicare Australia CEO
substitute:
Chief Executive Medicare
[11] Section 13, Subsection (3)
Omit (all instances):
Medicare Australia CEO
substitute:
Chief Executive Medicare
[12] Section 13, Subsection (4)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
[13] Section 13, Subsection (6)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
[14] Section 22, Paragraph (a)
omit:
Medicare Australia
substitute:
the Department of Human Services
[15] Section 22, Paragraph (b)
omit:
Medicare Australia
substitute:
the Chief Executive Medicare
[16] Section 22, Subparagraph (c)(iii)
omit:
Medicare Australia
substitute:
the Chief Executive Medicare
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0